• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. CONSERVE FEMORAL RESURFACING HEAD 50MM; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. CONSERVE FEMORAL RESURFACING HEAD 50MM; HIP COMPONENT Back to Search Results
Model Number 38031050
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Code Metal Related Pathology (4530)
Type of Reportable Event Serious Injury
Event or Problem Description
Allegedly, patient was revised due to adverse soft tissue reaction to particle debris revision njr number: (b)(4).Side: l.Primary asa: p1 - fit and healthy.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONSERVE FEMORAL RESURFACING HEAD 50MM
Common Device Name
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key10777527
Report Number3010536692-2020-00682
Device Sequence Number3884328
Product Code KXA
UDI-Device IdentifierM684380310501
UDI-PublicM684380310501
Combination Product (Y/N)N
Initial Reporter CountryGB
PMA/510(K) Number
K944752
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2010
Device Explanted Year2020
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 11/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number38031050
Device Catalogue Number38031050
Device Lot Number69863254
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date10/19/2020
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/19/2020
Initial Report FDA Received Date11/03/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-